Онкология
2290 статей · 70 журналов
Журналы подкатегории (70)
- EJC Skin Cancer · Elsevier (91)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (90)
- Blood Neoplasia · Elsevier (90)
- The Lancet Oncology · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (85)
- European Journal of Surgical Oncology · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (81)
- International Journal of Gynecological Cancer · Elsevier (80)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (69)
- European Journal of Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (67)
- Leukemia Research Reports · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (64)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (54)
- The Journal of Liquid Biopsy · Elsevier (53)
- Leukemia Research · Elsevier (52)
- Cancer Letters · Elsevier (51)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Current Problems in Cancer: Case Reports · Elsevier (30)
- Journal of Geriatric Oncology · Elsevier (30)
- Journal of Bone Oncology · Elsevier (29)
- Intelligent Oncology · Elsevier (20)
- Precision Radiation Oncology · Wiley (20)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- Best Practice & Research Clinical Haematology · Elsevier (12)
- npj Precision Oncology · Springer Nature (12)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- British Journal of Cancer · Springer Nature (8)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
-
Risvutatug rezetecan has promising efficacy in osteosarcoma
Nature Reviews Clinical Oncology, Published online: 09 November 2026; doi:10.1038/s41571-026-01228-w Risvutatug rezetecan has promising efficacy in osteosarcoma
-
Long-term fatigue dimensions in the Multidimensional Fatigue Inventory (MFI) up to five years after radiotherapy and their trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study
British Journal of Cancer, Published online: 09 November 2026; doi:10.1038/s41416-026-03626-4 Long-term fatigue dimensions in the Multidimensional Fatigue Inventory (MFI) up to five years after radiotherapy and their trajectories in men...
-
Correction: Deep learning-based prediction of lymph node metastasis and occult tumor cells in gastric cancer using histopathological images: a retrospective study
British Journal of Cancer, Published online: 09 November 2026; doi:10.1038/s41416-026-03640-6 Correction: Deep learning-based prediction of lymph node metastasis and occult tumor cells in gastric cancer using histopathological images: a...
-
E2F1 signatures stratify immunotherapy response and reveal YWHAQ vulnerability in esophageal squamous cell carcinoma
npj Precision Oncology, Published online: 09 November 2026; doi:10.1038/s41698-026-01773-8 E2F1 signatures stratify immunotherapy response and reveal YWHAQ vulnerability in esophageal squamous cell carcinoma
-
SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer
British Journal of Cancer, Published online: 07 November 2026; doi:10.1038/s41416-026-03653-1 SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer
-
Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Sacituzumab tirumotecan–pembrolizumab has efficacy in PD-L1-negative NSCLC
Nature Reviews Clinical Oncology, Published online: 06 November 2026; doi:10.1038/s41571-026-01232-0 Sacituzumab tirumotecan–pembrolizumab has efficacy in PD-L1-negative NSCLC
-
Unprecedented OS with the addition of tarlatamab to first-line maintenance therapy for ES-SCLC
Nature Reviews Clinical Oncology, Published online: 06 November 2026; doi:10.1038/s41571-026-01227-x Unprecedented OS with the addition of tarlatamab to first-line maintenance therapy for ES-SCLC
-
Pollutant-induced activation of the AHR–NF-κB–C/EBPβ axis in colorectal cancer
npj Precision Oncology, Published online: 06 November 2026; doi:10.1038/s41698-026-01755-w Pollutant-induced activation of the AHR–NF-κB–C/EBPβ axis in colorectal cancer
-
Origins and heterogeneity of colorectal cancer
Nature Reviews Cancer, Published online: 06 November 2026; doi:10.1038/s41568-026-00988-y This Review by Sphyris et al. discusses how the cell-of-origin determines the route of colorectal carcinogenesis and how phenotypic plasticity and...
-
Which is more effective at improving uptake of bowel cancer screening: text message reminders or patient navigation? Results from a three-arm RCT
British Journal of Cancer, Published online: 05 November 2026; doi:10.1038/s41416-026-03645-1 Which is more effective at improving uptake of bowel cancer screening: text message reminders or patient navigation? Results from a three-arm RCT
-
Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
British Journal of Cancer, Published online: 05 November 2026; doi:10.1038/s41416-026-03651-3 Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in...
-
IL1B⁺ Tumor-associated macrophages arise from inflammatory cancer-associated fibroblasts niches and are correlated with head and neck squamous cell carcinoma recurrence
npj Precision Oncology, Published online: 05 November 2026; doi:10.1038/s41698-026-01771-w IL1B⁺ Tumor-associated macrophages arise from inflammatory cancer-associated fibroblasts niches and are correlated with head and neck squamous...
-
Dosimetric risk factors for therapy‐related pneumonitis in patients with immunotherapy plus chemotherapy concurrent thoracic radiotherapy
Abstract Objective Combining immune checkpoint inhibitors (ICIs) with chemoradiotherapy is being actively investigated to improve clinical outcomes; however, this strategy may also increase the risk of treatment‐related toxicities. This...
-
β‐Arrestin1 Promotes Prostate Cancer Progression via Modulating ESRP1‐Mediated Alternative Splicing of CD44
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study
British Journal of Cancer, Published online: 04 November 2026; doi:10.1038/s41416-026-03644-2 Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic...
-
Astrocytes drive stroke-induced glioma progression
Nature Reviews Cancer, Published online: 04 November 2026; doi:10.1038/s41568-026-01000-3 Ye et al. show that ischaemic stroke can drive glioma progression through microenvironmental remodelling of tumour-associated astrocytes.
-
A New Regulator Caspase‐5C Drives Intestinal Homeostasis by Potentiating Wnt Signaling Through Adenomatous Polyposis Coli (APC) Cleavage
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
A randomized clinical trial comparing visual inspection with acetic acid (VIA) to Pocket Colposcopy for the triage of HPV+ women living with HIV in Kisumu, Kenya
British Journal of Cancer, Published online: 03 November 2026; doi:10.1038/s41416-026-03609-5 A randomized clinical trial comparing visual inspection with acetic acid (VIA) to Pocket Colposcopy for the triage of HPV+ women living with...
-
Divergent Trends in Head and Neck Cancer Burden in China (1990–2021)
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Single-cell tumour phylogenetics
Nature Reviews Cancer, Published online: 26 October 2026; doi:10.1038/s41568-026-00992-2 Single-cell sequencing has transformed the study of tumour evolution by enabling high-resolution reconstruction of cancer phylogenies. This Review...
-
Circular RNA circERBB2 Promotes Tumorigenesis via the miR‐1587/CBX2 Axis and Epigenetic Silencing of PTEN in Bladder Cancer Cells
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Implementation and preliminary evaluation of a practical digital workflow for routine laser‐radiation field coincidence quality assurance on the CyberKnife M6
Abstract Purpose To implement and preliminarily evaluate a practical digital acquisition‐and‐analysis workflow for routine laser‐radiation field coincidence quality assurance (QA) on the CyberKnife M6 by integrating multileaf collimator...
-
Evaluation of Concordance between Radiation Therapists and Medical Physicists in MR‐Guided Online Adaptive Planning
Abstract Purpose Magnetic resonance (MR) ‐guided online adaptive radiotherapy requires skill in online adaptive treatment planning. The aim of this study was to demonstrate that radiation therapists, with appropriate training, can...
-
Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer.”
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Opioid Prescribing Changes in Advanced Cancer Before and After Withdrawal of Hydromorphone Slow‐Release Tablets
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone
Abstract This planning study evaluated ultra‐hypofractionated three‐dose‐level radiotherapy for prostate cancer with a dominant intraprostatic lesion (DIL) abutting the urethral high‐dose avoidance zone (HDAZ). Ten patients (30...
-
Global Burden and Trends of Early‐Onset Tracheal, Bronchus, and Lung Cancer Among Women From 1990 to 2021
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Response Letter: Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer”
Asia-Pacific Journal of Clinical Oncology, EarlyView.